Resources Contact Us Home
Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications

Image Number 6 for United States Patent #5843676.

The invention relates to novel purified human immunoglobulin E binding factors (IgE-BFs), its individual optionally glycosylated proteins, and fragments thereof, processes for the purification of IgE-BFs, novel monoclonal antibodies to lymphocyte cellular receptors for IgE (Fc.sub..epsilon. R) crossreacting with IgE-BFs, derivatives thereof, processes for the preparation of these antibodies and their derivatives, hybridoma cell lines that produce these antibodies, processes for the preparation of said hybridoma cell lines, the use of the monoclonal antibodies and their derivatives for the qualitative and quantitative determination of IgE-BFs, test kits containing the monoclonal antibodies and/or their derivatives, the use of the monoclonal antibodies for the purification of IgE-BFs, the use of purified IgE-BFs, its individual optionally glycosylated proteins and/or fragments thereof for the prevention and/or treatment of allergy, and to pharmaceutical preparations containing them. IgE-BFs and monoclonal antibodies reacting with IgE-BF are important for the diagnosis and therapy of allergic diseases.

  Recently Added Patents
Nitrogen-doped carbon-supported cobalt-iron oxygen reduction catalyst
Computerized information and display methods
Single-wavelength correction method for luminescent homogeneous biological assay
Mobile interactive kiosk method
  Randomly Featured Patents
Systems and methods for focusing optics
Oxygen plasma resistant polymer for electrical devices
Grain field marker
Photo-interrupter based force sensing handle and method of use
Configuration data feeding device
Audio jack connector
Uncompetitive inhibition of steroid and 5.alpha.-reductose
Multi-purpose log handling tool
Bonding of aligned conductive bumps on adjacent surfaces
Scientific calculator